Table 5.
Characteristics of subjects | P. vivax | P. falciparum | Mixed malaria | p-value |
---|---|---|---|---|
Sex, n (%) | ||||
Male | 49 (26.9) | 60 (33) | 3 (1.6) | 0.637a |
Female | 27 (14.8) | 42 (23.1) | 1 (0.5) | |
Age (years), median (range) | 6.67 (0.33-14) | 6 (0.08–15.67) | 1.88 (1.42–3) | 0.059b |
Age group, n (%) | ||||
< 5 years | 32 (17.6) | 41 (22.5) | 4 (2.2) | 0.226a |
5–10 years | 25 (13.7) | 34 (18.7) | 0 (0.0) | |
> 10 years | 19 (10.4) | 27 (14.8) | 0 (0.0) | |
Weight (kg), mean (SD) | 18.71 (11.77) | 19.49 (10.99) | 9.7 (0.36) | 0.069b |
Hemoglobin, n (%) | ||||
≤ 5 g/dL | 3 (1.6) | 9 (4.9) | 2 (1.1) | 0.005a |
5.1–10 g/dL | 34 (18.7) | 56 (30.8) | 1 (0.5) | |
> 10 g/dL | 39 (21.4) | 37 (20.3) | 1 (0.5) | |
Leukocytes, n (%) | ||||
< 6000 g/dL | 23 (12.6) | 50 (27.5) | 1 (0.5) | 0.065a |
6000–11.000 g/dL | 36 (19.8) | 36 (19.8) | 1 (0.5) | |
> 11.000 g/dL | 17 (9.3) | 16 (8.8) | 2 (1.1) | |
Platelets, n (%) | ||||
≤ 100.000 g/dL | 18 (9.9) | 37 (20.3) | 1 (0.5) | 0.192a |
> 100.000 g/dL | 58 (31.9) | 65 (35.7) | 3 (1.6) | |
Anemia, n (%) | ||||
Yes | 54 (29.7) | 83 (45.6) | 3 (1.6) | 0.270a |
No | 22 (12.1) | 19 (10.4) | 1 (0.5) | |
Thrombocytopenia, n (%) | ||||
Yes | 31 (17) | 65 (35.7) | 1 (0.5) | 0.005a |
No | 45 (24.7) | 37 (20.3) | 3 (1.6) | |
Grading anemia, n (%) | ||||
No anemia | 22 (12.1) | 19 (10.4) | 1 (0.5) | 0.256a |
Mild | 12 (6.6) | 15 (8.2) | 0 (0) | |
Moderate | 30 (16.5) | 37 (20.3) | 1 (0.5) | |
Severe | 12 (6.6) | 31 (17.0) | 2 (1.1) | |
Severe malaria, n (%) | ||||
Yes | 9 (4.9) | 13 (7.1) | 2 (1.1) | 0.087a |
No | 67 (36.8) | 89 (48.9) | 2 (1.1) | |
Hepatomegaly, n (%) | ||||
Yes | 9 (4.9) | 31 (17.0) | 1 (0.5) | 0.021a |
No | 67 (36.8) | 71 (39.0) | 3 (1.6) | |
Splenomegaly, n (%) | ||||
Yes | 7 (3.8) | 26 (14.3) | 1 (0.5) | 0.014a |
No | 69 (37.9) | 76 (41.8) | 3 (1.6) |
a Contingency coefficient correlation
b Kruskal-Wallis